Kyle T Greenway

13PUBLICATIONS
35CO-AUTHORS
Physical organic chemistryMedical biotechnology diagnostics (incl. biosensors)Clinical neuropsychologyPsychological methodology, design and analysisCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 17, 2026
Defining 'psychedelic'.

|Mar 21, 2026
Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach.

Claudio Agnorelli, Joseph Peill, Gabriela Sawicka

|Oct 28, 2025
A long, strange trip: Ketamine treatment in psychiatry.

David J Nutt, Celia Morgan, David Erritzoe

|Jun 18, 2025
The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression.

Kyle T Greenway, Nicolas Garel, Lê-Anh L Dinh-Williams

|Jun 12, 2025
Cross-disciplinary cardiovascular and psychiatric recommendations: A systematic review of clinical guidelines.

Marina Delli Colli, Kyle T Greenway, Michael Goldfarb

|Jun 03, 2025
An international Delphi consensus for reporting of setting in psychedelic clinical trials.

Chloé Pronovost-Morgan, Kyle T Greenway, Leor Roseman

Pageof 3

Frequent Collaborators

4 joint publications

David Erritzoe

3 joint publications

Robin Carhart-Harris

2 joint publications

David Nutt

2 joint publications

Leor Roseman